| Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes SA Brown, BP Kovatchev, D Raghinaru, JW Lum, BA Buckingham, ... New England Journal of Medicine 381 (18), 1707-1717, 2019 | 936 | 2019 |
| A randomized trial of closed-loop control in children with type 1 diabetes MD Breton, LG Kanapka, RW Beck, L Ekhlaspour, GP Forlenza, E Cengiz, ... New England Journal of Medicine 383 (9), 836-845, 2020 | 386 | 2020 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 271 | 2023 |
| Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial GP Forlenza, Z Li, BA Buckingham, JE Pinsker, E Cengiz, RP Wadwa, ... Diabetes care 41 (10), 2155-2161, 2018 | 268 | 2018 |
| ISPAD clinical practice consensus guidelines 2018: diabetes technologies JL Sherr, M Tauschmann, T Battelino, M de Bock, G Forlenza, R Roman, ... Pediatr Diabetes 19 (Suppl 27), 302-325, 2018 | 263 | 2018 |
| Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, ... Diabetes care 44 (7), 1630-1640, 2021 | 212 | 2021 |
| Safety evaluation of the MiniMed 670G system in children 7–13 years of age with type 1 diabetes GP Forlenza, O Pinhas-Hamiel, DR Liljenquist, DI Shulman, TS Bailey, ... Diabetes technology & therapeutics 21 (1), 11-19, 2019 | 194 | 2019 |
| Managing new-onset type 1 diabetes during the COVID-19 pandemic: challenges and opportunities SK Garg, D Rodbard, IB Hirsch, GP Forlenza Diabetes technology & therapeutics 22 (6), 431-439, 2020 | 189 | 2020 |
| The epidemic of type 1 diabetes: what is it telling us? GP Forlenza, M Rewers Current Opinion in Endocrinology, Diabetes and Obesity 18 (4), 248-251, 2011 | 186 | 2011 |
| A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings DC Klonoff, J Wang, D Rodbard, MA Kohn, C Li, D Liepmann, D Kerr, ... Journal of diabetes science and technology 17 (5), 1226-1242, 2023 | 179 | 2023 |
| Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study MD Breton, DR Cherñavvsky, GP Forlenza, MD DeBoer, J Robic, ... Diabetes care 40 (12), 1644-1650, 2017 | 170 | 2017 |
| Real world hybrid closed‐loop discontinuation: predictors and perceptions of youth discontinuing the 670G system in the first 6 months LH Messer, C Berget, T Vigers, L Pyle, C Geno, RP Wadwa, KA Driscoll, ... Pediatric diabetes 21 (2), 319-327, 2020 | 156 | 2020 |
| A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy C Berget, LH Messer, GP Forlenza Diabetes spectrum: a publication of the American Diabetes Association 32 (3 …, 2019 | 152 | 2019 |
| Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system LH Messer, GP Forlenza, JL Sherr, RP Wadwa, BA Buckingham, ... Diabetes Care 41 (4), 789-796, 2018 | 141 | 2018 |
| Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes S Alva, T Bailey, R Brazg, ES Budiman, K Castorino, MP Christiansen, ... Journal of diabetes science and technology 16 (1), 70-77, 2022 | 138 | 2022 |
| Six months of hybrid closed loop in the real‐world: an evaluation of children and young adults using the 670G system C Berget, LH Messer, T Vigers, BI Frohnert, L Pyle, RP Wadwa, ... Pediatric diabetes 21 (2), 310-318, 2020 | 138 | 2020 |
| Preserving skin integrity with chronic device use in diabetes LH Messer, C Berget, C Beatson, S Polsky, GP Forlenza Diabetes technology & therapeutics 20 (S2), S2-54-S2-64, 2018 | 117 | 2018 |
| Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial GP Forlenza, J McVean, RW Beck, C Bauza, R Bailey, B Buckingham, ... Jama 329 (12), 990-999, 2023 | 116 | 2023 |
| Successful at-home use of the tandem control-IQ artificial pancreas system in young children during a randomized controlled trial GP Forlenza, L Ekhlaspour, M Breton, DM Maahs, RP Wadwa, M DeBoer, ... Diabetes technology & therapeutics 21 (4), 159-169, 2019 | 115 | 2019 |
| Closed-loop control without meal announcement in type 1 diabetes FM Cameron, TT Ly, BA Buckingham, DM Maahs, GP Forlenza, CJ Levy, ... Diabetes technology & therapeutics 19 (9), 527-532, 2017 | 109 | 2017 |
